The discovery, detailed in a study in Current Biology, could inform a key strategy to protect the food supply in the face of climate instability, the researchers said. Agricultural productivity is ...
MOUNTAIN VIEW, Calif., March 26, 2026 (GLOBE NEWSWIRE)-- RenovoRx, Inc. ("RenovoRx” or "the Company”) (Nasdaq: RNXT), a life-sciences company developing innovative targeted oncology therapies and ...
Paradigm Biopharmaceuticals (ASX: PAR) has completed enrolment in its pivotal Phase 3 clinical trial evaluating Zilosul for ...
Hosted on MSN
Viking delays oral VK2735 Phase III start to Q4 2026
Viking Therapeutics has completed enrollment in both Phase 3 VANQUISH trials for its injectable obesity drug VK2735 and now plans to start Phase 3 testing of its oral version in the fourth quarter of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results